| Ansøgningsnr. og dato | 14722018.0 (espacenet) (Federated) (European Patent Register), 20140313 | | Patent/reg.nr. og dato | DK/EP 2970974, 20170823 | | Tilgængelighedsdato | 20160120 | | Prioritetsnr. og dato | US 201361782531 P, 20130314, US 201361837399 P, 20130620, US 201361904579 P, 20131115, US 201361912777 P, 20131206, US 201461942367 P, 20140220 | | EP publ. nr. og dato |
EP 2970974 20160120 | | Løbedag | | | Ansøger/indehaver | Alnylam Pharmaceuticals, Inc., 675 West Kendall Street Henri A. Termeer Square
Cambridge, MA 02142, US | | Ansøgers ref. nr. | ALN ALN-178EP | | Opfinder | RAJEEV, Kallanthottathil, G., 300 Third Street 3rd Floor
Cambridge, MA 02142, US, MANOHARAN, Muthiah, 300 Third Street 3rd Floor
Cambridge, MA 02142, US, BETTENCOURT, Brian, 300 Third Street 3rd Floor
Cambridge, MA 02142, US, FITZGERALD, Kevin, 300 Third Street 3rd Floor
Cambridge, MA 02142, US, MAIER, Martin, 300 Third Street 3rd Floor
Cambridge, MA 02142, US, KUCHIMANCHI, Satyanarayana, 300 Third Street 3rd Floor
Cambridge, MA 02142, US, CHARISSE, Klaus, 300 Third Street 3rd Floor
Cambridge, MA 02142, US, FOSTER, Donald, 300 Third Street
Cambridge, MA 02142, US, BORODOVSKY, Anna, 300 Third Street 3rd Floor
Cambridge, MA 02142, US, BUTLER, James, 300 Third Street 3rd Floor
Cambridge, MA 02142, US | | Fuldmægtig | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 31/7088 (2006.01) , C12N 15/113 (2010.01) | | Titel/benævnelse | KOMPLEMENTKOMPONENT C5-IRNA-SAMMENSÆTNINGER OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | | Internationalt ansøgningsnr. | US2014025882 | | Internationalt publ. nr. | WO2014160129 | | Relateret sag (certifikat) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|